GENE ONLINE|News &
Opinion
Blog

PD-1 Inhibitor
Lepu, HanX Scores China Approval For PD-1 Inhibitor
2022-07-27
Innovent, Lilly Bag Third Approval for PD-1 Inhibitor Tyvyt in China
2021-06-07
GSK’s Oncology Drug Acquired from Tesaro Notches Accelerated Approval for Endometrial Cancer
2021-04-25
BMS’s Combo Therapy Involving LAG-3 Drug Impresses in Melanoma Trial
2021-03-27
Libtayo’s Second Approval in One Month Sets Up Lung Cancer Duel with Merck’s Keytruda
2021-02-24
FDA Okay of Regeneron’s PD-1 Inhibitor Marks Entry of First Immunotherapy for Advanced Basal Cell Carcinoma
2021-02-12
Another Checkpoint Inhibitor Set to Make Market Appearance as FDA Grants Priority Review
2021-01-25
Roche’s Tecentriq Bags Landmark FDA Approval as First-Line Monotherapy for Metastatic NSCLC
2020-05-20
The Evolution of Lung Cancer Therapies at a Glance
2020-04-16
Weekly in Asia|Nov-3
2019-12-03
LATEST
Regeneron Steps In to Rescue 23andMe From Bankruptcy With $256M Acquisition
2025-05-20
Virtual trial shows combo rescue inhaler nearly halves severe asthma attacks
2025-05-20
Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition
2025-05-19
The Fight Against Hard-to-Treat Cancers : Bold Bets on a Multifaceted Approach
2025-05-19
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-19
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
EVENT
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top